Feng‐Xiang Zhang

Guangzhou Institutes of Biomedicine and Health

Papers

1

Total Citations

2

H-Index

1

About

Dr. Feng‐Xiang Zhang is a pioneering researcher in the field of regenerative medicine and cellular reprogramming, with a primary focus on somatic cell reprogramming and the generation of induced pluripotent stem cells (iPSCs). His most notable contribution is the development of a robotic-based spatial-restricting structured flow system for selecting monoclonal cell lineages from somatic reprogramming, a breakthrough published in 2024 that addresses the critical challenge of lineage heterogeneity in iPSC production. This innovative approach significantly reduces the risk of genetic and epigenetic abnormalities caused by extensive lineage manipulations, enhancing the safety and reliability of iPSCs for personalized disease modeling and therapeutic applications. Though his work is early-stage, with 2 citations to date, Dr. Zhang's research holds immense potential to streamline the production of high-quality seed cells for regenerative medicine. His achievements underscore a commitment to advancing precision cell engineering, positioning him as an emerging leader in the quest to make stem cell therapies more accessible and clinically viable.

Research Focus

Key Achievements

1
H-Index
1
Papers
2
Total Citations
2
Avg Citations/Paper
🏆 Most Cited Paper
Selecting Monoclonal Cell Lineages from Somatic Reprogramming Using Robotic-Based Spatial-Restricting Structured Flow
2 citations · 2024
📈 Most Prolific Year: 2024 (1 Papers)
🤝 Key Collaborators: 26
🏛 Institutions: Guangzhou Institutes of Biomedicine and Health

Top Papers

  1. 1

Key Collaborators

Contact & Links

Available for collaboration
Content generated · 13 days ago